BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
 
Syngene - New Chemiluminescence Image Analyser Guarantees High Resolution for Greater Accuracy

March 12th 2004, Cambridge, UK: Syngene, a world-leading manufacturer of image analysis solutions, today introduced its new ChemiGeniusQ, high resolution, multi-functional image analyser. This new system offers exceptional resolving power to automatically and accurately separate close band and spot images.

Inside its own compact light-tight darkroom, the ChemiGeniusQ has cutting edge, 12 bit, cooled camera technology. With a megapixel resolution of 1392 x 1040 pixels, the fully integrated camera ensures the ChemiGeniusQ has the best resolving capacity of any system in its class. Also essential for precise sample quantification, ChemiGeniusQ has excellent quantum efficiency across a range of wavelengths, allowing users to measure even the faintest chemiluminescent or fluorescent signals.

The versatile ChemiGeniusQ has built-in FIREWIRE technology so it can handle a variety of chemiluminescence, fluorescence and visible imaging tasks all in real-time. This benefits users by allowing them to position samples and leave chemiluminescence blots to develop unattended, while the system captures a series of real-time images. ChemiGeniusQ comes complete with Syngene’s GeneTools image analysis software, which saves hours of repetitive manual analysis by automating 2D spot densitometry, lane analysis and colony counting as well as band or spot matching and multi-layer gel analysis.

Laura Sullivan, Syngene’s Divisional Manager explained: “To separate images of close bands and spots – the quality of the digital camera is crucial. At Syngene we believe in keeping up to date with all aspects of imaging technology and this is why we have used a newly available, high specification camera. By skilfully integrating a great 12 bit, cooled camera with our new image capture and analysis software we have guaranteed that the ChemiGeniusQ outperforms any other multi-purpose image analyser of its type on the market today, and will significantly improve the accuracy of those all important results.”

-Ends-


 

For Further Information Contact:

Jayne Arthur, Syngene, Beacon House, Nuffield Road, Cambridge, CB4 1TF, UK.

Tel: +44(0) 1223-727123 Fax +44 (0) 1223-727101

Email: jayne.arthur@syngene.com  Web site: www.syngene.com 

 

Editor Contact:

Dr Sue Pearson, PO Box 170, Hitchin, Hertfordshire SG5 3GD, UK.

Tel/Fax 00 44 1462- 635327 Email: sue6.pearson@ntlworld.com

Note to Editors

Syngene is a world-leading supplier of integrated imaging solutions for analysis and documentation of gel-based information. Syngene’s systems are used by more than 10,000 research organisations and over 50,000 individual scientists world-wide and include many of the world’s top pharmaceutical companies and major research institutes.

Syngene, founded in 1997 is a division of the Synoptics Group based in Cambridge, UK. The Group’s other divisions, Syncroscopy and Synbiosis, specialise in digital imaging solutions for microscopy and microbial applications respectively. Synoptics currently employs 50 people in its UK and subsidiary operation in Frederick, USA. The Group has profitable revenue of almost $10 million and continues to grow rapidly.

 
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.